Retatrutide Will Send a Shockwave Through the GLP-1 World
Phase 2 data show roughly 24% mean weight loss at 48 weeks with retatrutide. With Phase 3 and an outcomes trial underway, here is how a triple agonist could reset the GLP-1 era.
Evidence-based guides, provider comparisons, and treatment insights to help you choose the right care.
Phase 2 data show roughly 24% mean weight loss at 48 weeks with retatrutide. With Phase 3 and an outcomes trial underway, here is how a triple agonist could reset the GLP-1 era.
Titration means gradually increasing the dose over time. For GLP‑1s, titration lets your body adapt to effects on appetite and gastric emptying.
Patients often ask us how 503A vs 503B pharmacies differ and why it matters for safety, access, and cost. The distinction affects whether a medication is compounded for a single named patient or produced in larger lots for clinic use, which quality standards apply etc..
If you have been exploring wellness or longevity, you have likely heard about NAD+. It is promoted for energy, healthy aging, and recovery. This guide explains what NAD+ is, how it works, who might benefit, safety basics, and how to access it through a clinician.